ProPhase Labs, Inc. — Director's Dealing 2022

Apr 11, 2022

SEC Form 4/A — Form 4/A

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-03-10

Reporting Person: Barr Jason Michael (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-10	Common Stock, par value $0.0005	P	721	$6.48	Acquired	30962	Direct

Footnotes

F1: The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program.

F2: The original Form 4 filed on March 16, 2022 mistakenly reported that the Reporting Person acquired 750 shares pursuant to an automatic broker-administered dividend reinvestment program.